A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity
Phase 2
220
about 1.2 years
18–65
2 sites in AZ, NE
About this study
This trial is testing how well different doses of the medicine NNC0662-0419 help people living with overweight or obesity. The purpose of it is to find out if NNC0662-0419 is safe and effective for treating people living with overweight or obesity. There are 2 trial treatments in this trial, participants will get either NNC0662-0419, the treatment being tested or placebo, a treatment that has no active medicine in it.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take NNC0662-0419
- 2.Take Placebo
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Primary: Part A: Number of treatment-emergent adverse events (TEAE), Part B: Relative change in body weight
Secondary: Part A: AUC; the area under the NNC0662-0419 plasma concentration-time curve, Part A: Change in body weight, Part A: Cmax; the maximum plasma concentration of NNC0662-0419, Part A: Relative change in body weight, Part B: Body weight reduction greater than or equal to (≥) 5% (Yes/No), Part B: Body weight reduction ≥ 10% (Yes/No), Part B: Body weight reduction ≥ 15% (Yes/No), Part B: Body weight reduction ≥ 20% (Yes/No)
Endocrinology